US Patent 9296722 Azolyl urea compounds and methods of use thereof
Patent 9296722 was granted and assigned to Ambit Biosciences on March, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+230 characters)
Article
Patent abstract
Provided herein are azolyl urea compounds for treatment of CSF-1R kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Gang Liu0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09296722 Azolyl urea compounds and methods of use thereof US Patent 9296722 Azolyl urea compounds and methods of use thereof
Infobox
Patent Number
09296722
Patent Number
9296722
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09296722 Azolyl urea compounds and methods of use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09296722
Date of patent
March 29, 2016
Patent application number
13700121
Date Filed
May 26, 2011
Patent primary examiner
Find more entities like US Patent 9296722 Azolyl urea compounds and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.